← Back to directory

Andrea Fülöp

Researcher Next ID · RN-014000

Researcher · Medicine

Országos Korányi Tbc és Pulmonológiai Intézet

, Hungary

Not currently recruitingFunding unknown
Works count
25
Citation count
18,269
H-index
12
i10-index
13

Research interests

Medicine
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies
Radiomics and Machine Learning in Medical Imaging

Publications

  • Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

    Journal of Clinical Oncology · 2021 · 10.1200/jco.21.00174

  • Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

    Journal of Clinical Oncology · 2019 · 10.1200/jco.18.00149

  • Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1810865

  • Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

    The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30690-3

  • Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1606774

Current projects

    No projects listed.